(Q57589626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Oxybutynin extended release and tolterodine immediate release : a health economic comparison (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

D Getsios

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

K J Ishak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

W El-Hadi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

K Payne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

D Albrecht

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

W Feng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

D Dubois

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

M O'connel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

81-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

Urinary incontinence in older people in the community: a neglected problem?

30 December 2019

cites work

1 reference

12 December 2020

Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study

1 reference

12 December 2020

Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine

1 reference

12 December 2020

The Overactive Bladder: From Basic Science to Clinical Management Consensus Conference. Proceedings. London, England, June 29, 1997

1 reference

12 December 2020

Pharmacotherapy of the overactive bladder and advances in drug delivery

1 reference

12 December 2020

Prevalence of urinary incontinence and its relationship with health status

1 reference

12 December 2020

Annual direct cost of urinary incontinence.

1 reference

12 December 2020

Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine

1 reference

12 December 2020

Cost-effectiveness of new treatments for overactive bladder: the example of tolterodine, a new muscarinic agent: a Markov model

1 reference

12 December 2020

Urge incontinence: the patient's perspective

1 reference

12 December 2020

Treatment patterns and associated symptom improvement during six months of care for overactive bladder: a prospective, observational study.

1 reference

12 December 2020

Economic costs of urinary incontinence in 1995.

1 reference

12 December 2020

A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder.

1 reference

12 December 2020

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

1 reference

12 December 2020

Use and costs of incontinence pads in female study volunteers. Continence Program for Women Research Group

1 reference

12 December 2020

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

12 December 2020

Incontinence drug utilization patterns in Québec, Canada.

1 reference

12 December 2020

Advancements in pharmacologic management of the overactive bladder

1 reference

12 December 2020

Economic considerations and outcome measurement in urge incontinence.

1 reference

12 December 2020

Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET).

1 reference

12 December 2020

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

1 reference

12 December 2020

A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance.

1 reference

12 December 2020

A Pharmacoeconomic Model Comparing Two Long-Acting Treatments for Overactive Bladder

1 reference

12 December 2020

Calculating the direct costs of urinary incontinence: a new test instrument

1 reference

12 December 2020

Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life

1 reference

12 December 2020

Economic considerations in overactive bladder

1 reference

12 December 2020

The newer antimuscarinic drugs: bladder control with less dry mouth

1 reference

12 December 2020

10.2165/00044011-200424020-00003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516694%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference